Back

Pharma

3rd Pharma 4.0 Summit

  • 1st – 2nd October 2024
  • Germany flag Germany Berlin

Welcome to the 3rd Pharma 4.0 Summit, where innovation meets pharmaceutical excellence in the heart of Berlin! As the pharmaceutical industry continues to evolve in the era of Industry 4.0, the #VLPharma40 summit serves as a catalyst for exploring cutting-edge technologies, disruptive trends, and transformative strategies shaping the future of pharmaceutical manufacturing and operations.

Join us for two days of insightful discussions, engaging presentations, and invaluable networking opportunities with industry leaders, experts, and innovators. 

Read more

About the 3rd Pharma 4.0 Summit  (#VLPharma40)

Embark on a transformative journey at the 3rd Pharma 4.0 Summit, set to unfold on October 1-2, 2024, in Berlin, Germany. Immerse yourself in the convergence of digital technologies and the pharmaceutical realm, revolutionizing every facet from drug development to manufacturing and patient care.

The #VLPharma40 summit gathers industry experts, thought leaders, professionals, researchers, and policymakers to discuss the latest trends, advancements, and challenges in Pharma 4.0.

Engage with esteemed keynote speakers who will share their knowledge and visionary insights, pushing the boundaries of what's possible:

  • Harnessing the Power of Data: Explore how pharmaceutical companies can leverage big data, analytics, and artificial intelligence to optimize manufacturing processes, improve supply chain efficiency, and enhance decision-making.
  • Implementing Digital Manufacturing Technologies: Learn about the latest advancements in digital manufacturing technologies such as IoT, robotics, automation, and cloud computing, and discover practical strategies for their successful implementation in pharmaceutical operations.
  • Ensuring Data Security and Compliance: Understand the importance of data security and regulatory compliance in Pharma 4.0 initiatives, and explore best practices for safeguarding sensitive information and meeting regulatory requirements.
  • Driving Innovation in Drug Development: Discover how Pharma 4.0 technologies are revolutionizing drug discovery, development, and clinical trials, and learn how to accelerate innovation while maintaining high standards of safety and efficacy.
  • Enhancing Patient Engagement and Personalized Medicine: Explore how Pharma 4.0 is enabling the shift towards patient-centric healthcare and personalized medicine, and learn strategies for leveraging technology to improve patient outcomes and satisfaction.
  • Navigating the Digital Transformation Journey: Gain insights into the challenges and opportunities associated with digital transformation in the pharmaceutical industry, and learn from real-world case studies and success stories.
  • Building Collaborative Ecosystems: Understand the importance of collaboration and partnerships in driving innovation and success in Pharma 4.0, and explore strategies for building and nurturing collaborative ecosystems within and beyond the pharmaceutical sector.
  • Future Trends and Emerging Technologies: Stay ahead of the curve by exploring future trends and emerging technologies that are shaping the future of pharmaceutical manufacturing, R&D, and commercialization.

Connect and collaborate with like-minded professionals, participate in interactive panel discussions, and gain invaluable insights to enhance efficiency, reduce costs, and improve patient outcomes. Join #VLPharma40 at the forefront of innovation, shaping the future of pharma and digital transformation.

Register today for the 3rd Pharma 4.0 Summit in Berlin and secure your place among industry leaders. Take this unique opportunity to be part of a dynamic event where knowledge meets innovation. We look forward to welcoming you in October 2024! 

Who should attend:

Chief Executives, Vice Presidents, Directors, Heads, Leaders, and Managers specialising in:

 

  • Medical Devices 
  • Robotics & Control 
  • CMC (Chemistry, Manufacturing, and Controls) 
  • Continuous Processing 
  • Cell Culture Technology 
  • Commercialisation 
  • Digital Strategy & Transformation 
  • Data Integrity 
  • Diagnostics 
  • Quality Assurance/Control 
  • Pharmaceutical Manufacturing 
  • Product Quality 
  • Process Monitoring 
  • Packaging 
  • Compliance 
  • Emerging Technologies 
  • Licensing 
  • Lifecycle Management 
  • Regulatory Affairs & Licensing 
  • Risk Management 
  • Research & Development 
  • Track & Trace 
  • Scale-Up & Tech Transfer 
  • Sterilization 
  • Supply Chain 
  • Validation 
  • Vaccines 
  • Biotechnology 
  • Precision Medicine 
  • Gene Therapy 
  • Bioinformatics 
  • Clinical Operations 
  • Data Science 
  • Pharmacovigilance 
  • Market Access 
  • Health Economics 
  • Digital Marketing 
  • Artificial Intelligence Ethics 
  • Patient Engagement 
  • Sustainability 
  • Clinical Research 
  • Drug Safety 
  • Regulatory Compliance 
  • Contract Manufacturing 
  • Outsourcing 
  • Intellectual Property 
  • Pharmacology 
  • Formulation Development 
  • Clinical Data Management 
  • Medical Affairs 
  • Health Technology Assessment 
  • Supply Chain Optimization 
  • Gene Editing 
  • Drug Delivery Systems 
  • Nutraceuticals 
  • Pharmacogenomics 

Register by June 30

The Early Bird Offer expires in 9 days!

REQUEST A BROCHURE

To request an agenda for this Summit, please complete the details below. We will send you the agenda via email.

KEY PRACTICAL LEARNING POINTS

  • Data Optimization: Utilize big data, AI, and analytics to enhance manufacturing processes and supply chain efficiency.
  • Digital Manufacturing: Implement IoT, robotics, and automation for streamlined operations and improved productivity.
  • Compliance Assurance: Ensure data security and regulatory compliance in Pharma 4.0 initiatives.
  • Innovative Drug Development: Leverage Pharma 4.0 technologies to accelerate innovation in drug discovery and development.
  • Personalized Medicine: Explore how technology enables personalized healthcare and patient engagement.
  • Digital Transformation: Navigate the challenges and opportunities of digital transformation in the pharmaceutical industry.
  • Collaborative Partnerships: Foster collaborative ecosystems to drive innovation and success.
  • Future Trends: Stay updated on emerging technologies shaping the future of pharmaceutical

Register by June 30

The Early Bird Offer expires in 9 days!

Dr. Jens Smiatek, DE

Digital Lead at Development NCE

Boehringer Ingelheim Pharma GmbH & Co. KG

Jens Smiatek has a PhD and habilitation in theoretical physics. He has taken various group leader positions in universities and research organisations, and his main biotechnological interests include modelling and advanced machine learning of coupled and single unit operations and formulation aspects. He is the author of more than 100 peer-reviewed articles with over 2600 citations (H-index 32). Since 2019, Jens has worked at Boehringer Ingelheim Pharma GmbH & Co. KG.

Richard Denk, CH

Senior Consultant, Aseptic Processing & Containment

Skan AG

Richard Denk has studied mechanical engineering and did an examination on experts of GMP, qualification and validation, pharmaceutical auditing, phar­maceutical engineering, and quality control at the University of Applied Sciences in Albstadt/Sigmaringen, Germany. Richard works at SKAN AG, headquartered in Allschwil, as the head of sales containment. He founded the expert con­tainment group of the ISPE DACH eight years ago. The containment group published the containment manual in September 2015. Richard has spent nearly 20 years working with highly active/highly hazardous substances and has developed the containment pyramid.

Dr. Natasha Hunsjee, CH

Global Integrated Medical Engagement Catalyst, Medical Affairs

Hoffmann La-Roche 

Executive Coach. Storyteller. Public speaker. Highly motivated, fast learner with strong dedication. Extensive scientific (BSc, MSc and PhD) background with over 20 years of pharmaceutical experience: sales, local & global strategic product management; global product commercial strategy training; scientific communications; digital innovation; mentoring, coaching and facilitating. Worked across all stages of the lifecycle (early launch, launch, LoE). Speaks several languages and has good interpersonal skills. 
Specialties: Experience in the following disease areas: Immunology, Infectology, Haematology, Urology, Oncology, Transplantation, Cardiovascular, and Neuroscience. 

Dr. Christoph Herwig, AT

Senior Scientific Advisor

Körber Pharma

Christoph Herwig, bioprocess engineer from RWTH Aachen and obtained a PhD in bioprocess identification at EPFL, Switzerland.  From 2008 to 2023, he was full professor for biochemical engineering at the Vienna University of Technology. The research area focused on the development of data science methods for integrated and efficient bioprocess development along PAT and QbD principles for biopharmaceuticals.  During his employments in various industries, such as with Lonza, he was deeply involved in the design and commissioning of large chemical and biopharmaceutical facilities. In 2013 he founded the company Exputec, which is now part of Körber Pharma, pioneering data science software solutions for the biopharma life cycle. Here, Christoph currently also acts as senior scientific advisor for Körber.  In addition, Christoph is serial entrepreneur, currently, as CPO at fermify, he is focusing on the projection of precision fermentation on the commercialization of vegan cheese.

Dr. Stephen Framil, US

Corporate Global Head of Accessibility

Merck Sharp & Dohme GmbH

As the corporate global head of accessibility at Merck Sharp & Dohme GmbH (MSD), Dr. Stephen Framil has threaded the values of equal access throughout his formative and professional career – from building greenhouses for the Navaho Nation in New Mexico and brick and mortar schools in the Dominican Republic, to creating a Philadelphia inner city tuition-free music conservatory for at-risk neighborhood youth, to performing arts organisations in Pennsylvania and North Carolina that make great music accessible to all through admission free concerts. Steve has brought his multi-faceted diverse experience and sense of mission-calling purpose to mobilise digital accessibility across MSD, unifying thought leadership with business objectives and technical expertise to make the digital landscape accessible to all. Steve has over 25 years of professional experience with executive leadership in business strategy and innovation, policy and governance, procedure and operations, and portfolio management expertise – leading global cross organisational enterprise, consultant, and startup teams in the health and life sciences, finance services, non-profit, information technology, user experience, and marketing.

Dan Bach Kristensen, DK

Scientific Director

Symphogen

Dan Bach Kristensen holds a PhD in biology and a BSc degree in chemistry. Dan is specialised in protein chemistry and mass spectrometry, which he initially applied in the field of proteome research. For the last 19 years Dan has been working with analytical development in the biopharmaceutical industry, on projects ranging from early discovery to product registration. Clinical indications include bleeding disorders, neutropenia, autoimmune diseases, and oncology. Dan currently works as a principal scientist at Symphogen, a part of Servier, which specialises in the development of antibodies, antibody formats, and antibody mixtures for the treatment of cancer and neuro inflammatory diseases.

Dr. Alexander Krupp, DE

Innovation Lead, Clinical Development and Operations

Bayer AG

Alexander Krupp is responsible for the transformation of Bayer’s clinical development business towards innovative trial designs and to ensure seamless interactions with the ecosystem of discovery partners. He is passionate about delivering digital strategy in the life sciences industry. Previously, his organisations have delivered plug and play data to be easily usable, e.g. 293m patient records from 30-plus sources. As an enthusiastic executive in global enterprises with a PhD in neuroscience, molecular oncologist and certified paramedic, his professional experience covers the pharmaceutical value chain with a focus on digital health and data strategy.

Dr. Wolfgang Sommeregger, AT

CEO

QUBICON AG

Wolfgang Sommeregger is co-founder of the company QUBICON AG, which focusses on software for advanced process monitoring and model-based process control. He obtained a degree in biotechnology, as well as a PhD as part of the doctoral program “Biomolecular Technology of Proteins (BioToP)” from the University of Natural Resources and Applied Life Sciences, Vienna (BOKU). During his doctoral studies and his former professional career, he mainly focussed on the improvement of bioprocesses, their monitoring, and control.

Sesethu Dowiasch, DE

Account Manager, Life Science & Chemical Industry

Rockwell Automation

Sesethu Dowiasch brings with her more than 15 years of hands-on experience in automation and digitalization in Africa, Europe, and USA. In her current role, she helps Life Science manufacturers transform their manufacturing operations to bring innovative treatments to patients faster, while improving quality, yield, and product security. Her practical background in automation and mechatronics engineering gives her a unique perspective on the impact of converging IT and OT through a scalable digital transformation journey. In addition to the strategy development for process control systems and secure network architecture design, Sesethu also supports manufacturers with the vertical and horizontal integration between systems such as Batch, DCS, MES, Historian, IOT, ERP, Cloud, etc. Sesethu also serves as the Co-Chair for the ISPE Women In Pharma community of practice in the DACH region. She is passionate about applying her engineering background to support the Life Science industry because of the positive impact it has in the lives of patients.

Bora Erdemli, CH

Principal

ZS Associates

Bora Erdemli has extensive medical affairs experience, leading ZS’s medical affairs practice in Europe. He has worked with pharmaceutical, biotech and medical technology/device companies globally. His focus has been on helping pharmaceutical companies develop sound medical affairs strategy, devise the right evidence/data generation plan, disseminate the information effectively, and collect/communicate insights back to the organisation.

Bora is a member of Medical Affairs Professional Society (MAPS) digital strategy focus area working group and co-leading the MAPS Switzerland/Nordics chapter. Prior to his current role, Bora worked as a management consultant within the healthcare and pharmaceutical practice of another global consulting firm. Bora holds a PhD in biophysics from the Johns Hopkins University School of Medicine.

Sunil Patel, US

Former Director of Centre of Excellence

ValGenesis, Inc. 

Sunil has over 17 years of experience working in the engineering and validation fields of cGMP / FDA / EU / ISO regulated industry sectors.  

Sunil has a strong background in Cleaning Validation (CIP, COP, Manual), Process Validation, Process Design, Clean Utilities (WFI, PW, Clean Steam, Clean Air, Clean Gases), HVAC, Project Management, Sterilization and Processing Equipment Validation. Further expertise includes Process Optimization/Improvement, Regulatory Compliance and Risk Management methodologies for the pharmaceutical and biologics industry.  

Prior to joining Valgenesis, Sunil has had variety of Validation roles as consultant and corporate employee with increased responsibilities within Pharmaceutical and Biologics industry including Catalent, Eisai, Pfizer, Teva and Novartis.  

Lukáš Dvořák, MSc, CZ

Independent Pharmaceutical Consultant

LD Consulting

Lukáš Dvořák is a pharmaceutical consultant with more than 15 years of experience in the pharmaceutical industry over Europe and Asia territories. He mainly focusses on the establishment and maintenance of the pharmaceutical quality systems, both production and quality practice. He has auditor skills and practise and is a professional adjudicator in the Czech Accreditation Institute.

Stephen Judd, IR

Process SME - Biologics/Cell & Gene Therapy

Arcadis l DPS Group Global

Stephen Judd is a chartered chemical engineer and fellow of engineers Ireland. He is an experienced technical manager and principal process engineer with more than 15 years’ experience in process engineering and facility design, mainly in biotech projects. He has an excellent mix of design office and field experience across a wide range of international clients with significant experience in process technology selection and facility design. He has experience across the full project life cycle from feasibility study to commissioning and qualification and now focusses on the early project phases developing the facility design and manufacturing philosophies. Stephen has significant experience with different process technologies across all parts of the manufacturing process for biologics, ATMP, and other novel therapies such as SPPS and mRNA vaccines. This includes selecting the optimum approach to suit the specific needs of the client/project with respect to hard-piped, single-use, or hybrid systems.

Stephen has also authored or co-authored a number of technical papers including a paper on multi-modal facility design published in the ISPE PE Magazine. He is actively involved in the development of a number of ISPE guides currently in development relating to C&GT topics.

Dr. Dimitrios Lamprou, UK

Full Professor (Chair) of Biofabrication and Advanced Manufacturing & Director at MSc Industrial Pharmaceutics

Queen’s University Belfast (QUB)

Dimitrios Lamprou (PhD, MBA) is a full professor (chair) of biofabrication and advanced manufacturing, and a director at MSc industrial pharmaceutics at Queen’s University Belfast (QUB). He is also the chair at United Kingdom and Ireland Controlled Release Society (UKICRS) and the chair of the Academy of Pharmaceutical Sciences (APS) emerging technologies focus group. Dimitrios is the author of over 150 peer-reviewed publications, has over 350 conference abstracts, has given over 150 invited talks in institutions and conferences across the world, and has secured funding of more than £4M.

Dimitrios has been recognised as a world leader in 3D printing and microfluidics. PubMed-based algorithms placed him in the top 0.088% of scholars in the world writing about 3D printing and in the top 0.071% of scholars in the world writing about microfluidics in the past 10 years. Moreover, PubMed-based algorithms placed him in the top 0.63% of scholars in the world writing about nanofibers.

Dimitrios has also twice been named in Stanford University’s list of the world’s top 2% scientists (2021 and 2022) for his research in pharmaceutics and biomedical engineering. His research and academic leadership have been recognised in a range of awards, including the Royal Pharmaceutical Society Science Award and the Scottish Universities Life Sciences Alliance Leaders Scheme Award. For more info, please visit www.emergingtechnologieslab.com.

Thomas Hauser, DE

Sales Director in the EMEA

C-CUBE  

Thomas Hauser is working since June 2023 for C-CUBE as a Sales Director in the EMEA region to educate the market for offsite prefabricated and prequalified turn-key factory and smart module concept in a drive to bring forward the pharmaceutical facility of the future concept.  

In his former work for G-CON and his consulting agency, he has supported companies in the life science segment mainly for expansion strategies, strategical facility implementation, start-up support and pharmaceutical packaging supply and technologies and in questions of manufacturing set-up. 

Before 2020, Thomas worked in various leading global positions in Business Development, Strategic Implementation and Sales in the Pharmaceutical Packaging field, namely in injectables, semi solid and oral solid packaging. He has more than 25 years of experience dealing with the global Lifesciences Industry and their market and manufacturing requirements.  

Thomas holds an International MBA from the University of Ottawa / Canada, and a BA for European Business from the ESB Reutlingen and the ESC Reims. 

Fabian Stutz, CH

CEO

Pharmabotix AG

Fabian Stutz is the CEO and founder of Pharmabotix, which is committed to revolutionising pharmaceutical production through innovative automation solutions. Their vision is to assist companies in the pharmaceutical sector in automating and robotising their processes, thereby enhancing the quality of their products, maximising efficiency, and reducing costs. They offer a comprehensive range of services, from feasibility studies to concept development and the realisation of turnkey systems.

Dr. Jens Smiatek, DE

Digital Lead at Development NCE

Boehringer Ingelheim Pharma GmbH & Co. KG

Richard Denk, CH

Senior Consultant, Aseptic Processing & Containment

Skan AG

Dr. Natasha Hunsjee, CH

Global Integrated Medical Engagement Catalyst, Medical Affairs

Hoffmann La-Roche 

Dr. Christoph Herwig, AT

Senior Scientific Advisor

Körber Pharma

Dr. Stephen Framil, US

Corporate Global Head of Accessibility

Merck Sharp & Dohme GmbH

Dan Bach Kristensen, DK

Scientific Director

Symphogen

Dr. Alexander Krupp, DE

Innovation Lead, Clinical Development and Operations

Bayer AG

Dr. Wolfgang Sommeregger, AT

CEO

QUBICON AG

Sesethu Dowiasch, DE

Account Manager, Life Science & Chemical Industry

Rockwell Automation

Bora Erdemli, CH

Principal

ZS Associates

Sunil Patel, US

Former Director of Centre of Excellence

ValGenesis, Inc. 

Lukáš Dvořák, MSc, CZ

Independent Pharmaceutical Consultant

LD Consulting

Stephen Judd, IR

Process SME - Biologics/Cell & Gene Therapy

Arcadis l DPS Group Global

Dr. Dimitrios Lamprou, UK

Full Professor (Chair) of Biofabrication and Advanced Manufacturing & Director at MSc Industrial Pharmaceutics

Queen’s University Belfast (QUB)

Thomas Hauser, DE

Sales Director in the EMEA

C-CUBE  

Fabian Stutz, CH

CEO

Pharmabotix AG

BROCHURE

Request the 3rd Pharma 4.0 Summit brochure and find out the latest topics and ideas that will be shared.

Request

Please fill in your e-mail address below and we will process your request in a moment.

What our
participants
are saying

I want to extend my gratitude and appreciation for providing such a quality platform for this very important part of our industry!  

1
2
3
4
5

Robert B. Wood IV

Scientist II at FUJIFILM Diosynth Biotechnologies

"We had very interesting discussions with the different participants about our industry and the latest trends. Thanks to Vonlanthen for organizing another great 4.0 oriented event."  

1
2
3
4
5

Paolo Bento

Regional Sales Manager at ILC Dover

"Big thank you to all the speakers at the #VLPharma40I Summit. Fantastic insights from a diverse group of industry experts and great presentations from all involved."  

1
2
3
4
5

Jessica Pearson

Occupational Hygiene Consultant at Armstrong Environmental Limited